Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

MTMR8 Inhibitors

MTMR8, or Myotubularin Related Protein 8, is a member of the myotubularin family of proteins that are involved in cellular processes such as endocytosis and signal transduction. The precise biological functions of MTMR8 are still being elucidated, but it is known to play a role in the phosphoinositide signaling pathway, which is critical for various cellular functions, including cell growth, proliferation, differentiation, and motility. The expression of MTMR8 is subject to complex regulatory mechanisms that ensure its levels are maintained within a range appropriate for normal cellular function. Dysregulation of MTMR8 expression can disrupt these cellular processes, making the study of its expression patterns and the identification of potential inhibitory compounds a significant area of interest for researchers in cell biology and molecular genetics. In the pursuit of understanding how to modulate MTMR8 expression, a number of chemical compounds have been identified that could serve as inhibitors, affecting the gene's expression indirectly or directly. These compounds typically interfere with cellular pathways that either control gene expression at the transcriptional level or affect post-transcriptional modifications. For instance, compounds like 5-Azacytidine and Decitabine might inhibit expression by causing DNA hypomethylation at the gene's promoter region, potentially leading to transcriptional repression of MTMR8. Histone deacetylase inhibitors, such as Trichostatin A and Vorinostat, can alter chromatin structure and histone modifications, which may result in a downregulation of MTMR8 gene transcription. Meanwhile, agents such as Rapamycin and Flavopiridol target signal transduction pathways and cell cycle progression, respectively, which could lead to a decrease in MTMR8 expression as part of a broader alteration of cellular function. These insights into the potential inhibition of MTMR8 are crucial for advancing our understanding of the molecular underpinnings that control the expression of this gene and its role in cellular physiology.

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Flavopiridol inhibits cyclin-dependent kinases, which may result in a blockade of the transcriptional cycle of genes, including the potential downregulation of MTMR8.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

Methotrexate inhibits dihydrofolate reductase, which may lead to decreased synthesis of thymidine and reduction in DNA replication, potentially inhibiting MTMR8 expression.